Cellectar biosciences inc stock

Get breaking news and analysis on Cellectar Biosciences, Inc. (CLRB) stock, price quote and chart, trading and investing tools. Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote ... Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital information to help you with your stock trading and investing.

Cellectar Biosciences Stock Forecast: up to 1260.690 USD ... Historical index on US Stock Market : D "Should I invest in Cellectar Biosciences stock?" "Should I trade "CLRB" stock today?" According to our live Forecast System, Cellectar Biosciences, Inc stock is an awesome long-term (1-year) investment*. "CLRB" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Cellectar Biosciences | Crunchbase Cellectar Biosciences, a radiopharmaceutical company, designs and develops products to detect, treat, and monitor various human cancers. Its products include 131I-CLR1404, a compound for cancer therapy. The company's product candidates combine lipid-like molecules and phospholipid ethers analogs with radioisotopes to image or destroy malignant CLRB Cellectar Biosciences, Inc. Stock Quote The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey. Cellectar Biosciences Inc : CLRB Stock Price Quote at Ally ...

View CLRB stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst.

Cellectar Biosciences, Inc. (CLRB) Stock Historical Prices ... Discover historical prices for CLRB stock on Yahoo Finance. View daily, weekly or monthly format back to when Cellectar Biosciences, Inc. stock was issued. CLRB | Cellectar Biosciences Inc. Stock Price & News - WSJ View the latest Cellectar Biosciences Inc. (CLRB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Cellectar Biosciences Inc., CLRB Quick Chart - (NAS) CLRB ... Cellectar Biosciences stock surges 23% premarket MarketWatch. Tuesday, July 17, 2018. 01:26 PM ET. Cellectar Biosciences shares surge 15% on results of one cancer patient in mid-stage trial MarketWatch. Wednesday, June 15, 2016. 09:16 AM ET. Cellectar's stock soars after positive results of a study of its tumor treatment MarketWatch. More CLRB Cellectar Biosciences, Inc. — Stock Price and ...

CLRB - Cellectar Biosciences Inc. • BioPharmCatalyst

Analyzing Kadmon (NYSE:KDMN) and Cellectar Biosciences ... Apr 07, 2020 · Cellectar Biosciences (NASDAQ:CLRB) and Kadmon (NYSE:KDMN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and …

CLRB | Cellectar Biosciences Inc. Stock Price & News - WSJ

19 Dec 2019 FLORHAM PARK, N.J., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage  Cellectar Biosciences, Inc. (CLRB) Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of … CLRB Stock Price | Cellectar Biosciences Inc. Stock Quote ... CLRB | Complete Cellectar Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Cellectar Biosciences, Inc. Common Stock (CLRB) Stock ...

Stock analysis for Cellectar Biosciences Inc (CLRB:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company 

Cellectar Biosciences Inc. [CLRB:US] | Cellectar ... Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Cellectar Biosciences Inc (CLRB) Quote | Morningstar Learn about CLRB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CLRB. Cellectar Biosciences Stock Forecast: up to 1260.690 USD ...

Cellectar Biosciences's stock reverse split on Tuesday, July 17th 2018. The 1-10 reverse split was announced on Friday, July 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 13th 2018. CLRB | Cellectar Biosciences Inc. Stock Price & News - WSJ Cellectar Biosciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CLRB stock price. NVLTD Stock Quote - Cellectar Biosciences Inc - Bloomberg ... Stock analysis for Cellectar Biosciences Inc (NVLTD) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cellectar Biosciences, Inc. (CLRB) Earnings Report ...